ClickSlim sells a product called NAD+ and footnotes it with the words CONTAINS TIRZEPATIDE, so no figure here is scoped to NAD+. It also prices the same weight-loss programme at two different monthly figures on one page.
What ClickSlim charges
Tirzepatide: $299/mo — per month for the card headed "Personalized GLP-1/GIP" and footnoted "*CONTAINS TIRZEPATIDE"; the same page prices the same programme at $199/month lower down
Tirzepatide: $199/mo — per month, the second figure the same page prints for the same programme, with nothing distinguishing it from the $299 one
ClickSlim also sells 1 compound this site boards without publishing a price for it: NAD+.
ClickSlim is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The NAD+ card carries a tirzepatide footnote
Read in document order, three cards run together on the homepage. The first is a weight-loss programme footnoted CONTAINS TIRZEPATIDE. The second is that programme plus NAD+, footnoted the same way. The third is headed NAD+ and carries the identical footnote.
A product sold as NAD+ that its own seller says contains a weight-loss drug is not a scoped NAD+ price, whatever the heading says.
No NAD+ figure is recorded on this row for that reason. The compound is declared, because the seller genuinely dispenses it.
One programme, two prices
The weight-loss programme is priced at one figure near the top of the page and at a considerably lower one further down, both described as per month and both for the same named programme.
A third block prices an introductory rate that steps up to a standing rate, and a fourth prices a standalone NAD+ programme with no billing period attached at all.
Both weight-loss figures are recorded as read. Nothing on the page distinguishes them and nothing here averages them.
What it says clearly
It says it is not a state-licensed pharmacy nor a drug manufacturer, and that medication is compounded and dispensed by a licensed third-party pharmacy.
It says compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality.
It prints the introductory rate and the standing rate together on its bundle offers rather than showing only the discount.
The gaps
It says its services are available in most states and publishes no list.
No dispensing pharmacy is named.
No certificate of analysis is reachable. A meaningless address on this host returns a not-found response, so those absences are absences.
Who it's for
Readers who read footnotes before believing a product name.
Buyers who want the introductory and standing rate shown together.
Shoppers who want a company to say it is not a pharmacy.
Anyone comparing a bundled programme against a standalone one.
Who should look elsewhere
Readers who want NAD+ on its own, without a weight-loss drug in it.
Buyers who need one settled price for a programme.
Anyone who needs a published state list or a named pharmacy.
Shoppers who require reachable testing documents.
Strengths
States that it is not a state-licensed pharmacy nor a drug manufacturer
Says compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality
Footnotes which of its products contain a weight-loss drug rather than leaving it to the intake
Prints the introductory rate and the standing rate together on its bundle offers
Trade-offs
Prices the same programme at two different monthly figures on one page
Sells a product called NAD+ that its own footnote says contains tirzepatide
Its standalone NAD+ figure carries no billing period at all
Publishes no state list, saying only that services are available in most states
How we verified this
Read the homepage in document order and attached each footnote to the card above it rather than to a neighbour.
Declined to record any NAD+ figure, because the card sold as NAD+ carries the seller's own CONTAINS TIRZEPATIDE footnote.
Recorded both weight-loss figures as read, and named in the qualifier that the same page prints the other.
Left the standalone NAD+ figure unrecorded, because it carries no billing period and no scoped ingredient.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand against the live federal warning-letter table, filtering locally because the table's own search parameter returns every record whatever is typed into it, with a positive and a nonsense control in the same run.
A provider to compare ClickSlim against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
The card headed NAD+ carries the seller's own footnote saying it contains tirzepatide, so what that figure buys is not a copper-bottomed NAD+ product. No NAD+ price is recorded here.
Which weight-loss price is right?
The site prints two, for the same named programme, on the same page. Both are on this record and neither is chosen.
Is this company a pharmacy?
It says it is not a state-licensed pharmacy nor a drug manufacturer, and that a licensed third-party pharmacy compounds and dispenses.
Which states does it serve?
It says most states and publishes no list, so no state coverage is recorded here.
ClickSlim is not a paid partner; this link may earn a commission if that changes. Full disclosure.